188 related articles for article (PubMed ID: 3548110)
1. Monitoring of renal allografts under immunosuppression.
Hammer C
Z Exp Chir Transplant Kunstliche Organe; 1986; 19(6):340-2. PubMed ID: 3548110
[No Abstract] [Full Text] [Related]
2. Conversion of cyclosporine to azathioprine in renal transplant patients.
Shen SY; Zemel SM; Weir MR; Dagher FJ; Bentley FR
Transplant Proc; 1987 Feb; 19(1 Pt 3):2032-6. PubMed ID: 3547906
[No Abstract] [Full Text] [Related]
3. Immunologic monitoring in OKT3-treated kidney graft recipients.
Zlabinger GJ; Maurer D; Ulrich W; Meron G; Pohanka E; Kovarik J
Transplant Proc; 1990 Aug; 22(4):1777-8. PubMed ID: 2117807
[No Abstract] [Full Text] [Related]
4. Renal transplantation in children using cyclosporin A and azathioprine.
Clark AG; Rigden SP; Welsh KI; Bewick M; Koffman G; Haycock GB; Chantler C
Transplant Proc; 1989 Feb; 21(1 Pt 2):1685-6. PubMed ID: 2652552
[No Abstract] [Full Text] [Related]
5. Synergistic effects of cyclosporine and steroid therapy in the induction of specific unresponsiveness to DLA-identical canine renal allografts.
Hayashi R; Meek AG; Arnold AN; Sonoda K; Ishimaru M; Strober S; Rapaport FT
Transplant Proc; 1989 Feb; 21(1 Pt 1):391-2. PubMed ID: 2650157
[No Abstract] [Full Text] [Related]
6. Early renal allograft rejection episodes are less aggressive with cyclosporin-A immunosuppression.
Merion RM; White DJ; Calne RY
Transplant Proc; 1983 Dec; 15(4):2172-7. PubMed ID: 6369690
[No Abstract] [Full Text] [Related]
7. Differential effects of immunosuppressive agents on mononuclear cells infiltrating human renal allografts.
Cunningham PR; Gross U; Matthews C; Sash C; Thomas F; Thomas J
Transplant Proc; 1989 Feb; 21(1 Pt 1):194-5. PubMed ID: 2650105
[No Abstract] [Full Text] [Related]
8. Primary dysfunction of renal allografts as a risk factor.
Margreiter R; Bösmüller C; Spielberger M; Königsrainer A; Dünser M
Transplant Proc; 1990 Aug; 22(4):1373-4. PubMed ID: 2389333
[No Abstract] [Full Text] [Related]
9. [Immunosuppression in kidney transplantation].
Grundmann R; Pichlmaier H
Dtsch Med Wochenschr; 1983 May; 108(18):687-9. PubMed ID: 6341031
[No Abstract] [Full Text] [Related]
10. The influence of immunosuppression on the prevalence of aseptic bone necrosis after renal transplantation.
Cotorruelo JG; De Francisco AL; Canga E; Amado JA; Riancho JA; De Bonis E; Zubimendi JA; Ruiz JC; Sanz de Castro S; Arias M
Transplant Proc; 1991 Aug; 23(4):2199-200. PubMed ID: 1871842
[No Abstract] [Full Text] [Related]
11. Fractional excretion of sodium during pulses of methylprednisolone for treatment of acute rejection in heart and kidney transplants.
Lloveras JJ; Tran Van T; Magues JP; Bernadet P; Durand D; Suc JM
Transplant Proc; 1990 Aug; 22(4):1384-5. PubMed ID: 2389337
[No Abstract] [Full Text] [Related]
12. The immunopharmacology of graft rejection.
Strom TB
Transplant Proc; 1987 Feb; 19(1 Pt 1):128-9. PubMed ID: 3274767
[No Abstract] [Full Text] [Related]
13. Trends in immunosuppression for kidney transplantation.
Butt KM; Zielinski CM; Parsa I; Elberg AJ; Wechter W; Kountz SL
Kidney Int Suppl; 1978 Jun; (8):S95-8. PubMed ID: 357820
[No Abstract] [Full Text] [Related]
14. Effective prevention of interstitial rejection crises in immunological high risk patients following renal transplantation: use of high doses of the new monoclonal antibody BMA 031.
Dendorfer U; Hillebrand G; Kasper C; Smely S; Weschka M; Hammer C; Racenberg J; Gurland HJ; Land W
Transplant Proc; 1990 Aug; 22(4):1789-90. PubMed ID: 2389450
[No Abstract] [Full Text] [Related]
15. Transfer of cytomegalovirus infection via renal allografts: role of immunosuppressive regimens on the transfer rate, and effect of cytomegalovirus infections on renal allograft rejection; study in a rat model.
Bruning JH; Bruggeman CA; van Breda Vriesman PJ
Transplant Proc; 1989 Feb; 21(1 Pt 2):2089-90. PubMed ID: 2540562
[No Abstract] [Full Text] [Related]
16. Heterotopic versus orthotopic heart transplantation.
Barnard CN; Cooper DK
Transplant Proc; 1984 Jun; 16(3):886-92. PubMed ID: 6375048
[No Abstract] [Full Text] [Related]
17. Clinical and experimental studies with cyclosporine in renal transplantation.
Kahan BD; van Buren CT; Flechner SM; Jarowenko M; Yasumura T; Rogers AJ; Yoshimura N; LeGrue S; Drath D; Kerman RH
Surgery; 1985 Feb; 97(2):125-40. PubMed ID: 3881837
[No Abstract] [Full Text] [Related]
18. Cellular components of renal lymph during allograft rejection: effect of immunosuppression.
Netto IC; Sakai A; Roberts AP; Cockett AT
Surg Forum; 1973; 24():554-6. PubMed ID: 4618673
[No Abstract] [Full Text] [Related]
19. Prophylactic use of an antilymphocyte monoclonal antibody following renal transplantation: a randomized controlled trial.
Friend PJ; Calne RY; Hale G; Waldmann H; Evans DB; Rolles K; Thiru S; Gore S
Transplant Proc; 1987 Feb; 19(1 Pt 3):1898-900. PubMed ID: 3079058
[No Abstract] [Full Text] [Related]
20. Treatment of transplant rejection in the presence of cytomegalovirus viremia.
O'Hair DP; Johnson CP; Roza AM; Adams MB
Transplant Proc; 1990 Aug; 22(4):1815-7. PubMed ID: 2167537
[No Abstract] [Full Text] [Related]
[Next] [New Search]
